Key result
A proposed unified statistical framework using flexible parametric models under competing risks allows for simultaneous assessment of correlate of protection and sieve effects in vaccine trials.
Why the study?
When a vaccine is not completely efficacious, methods are needed to simultaneously determine how vaccine effects differ conditional on immune responses and the type of infecting agent.
The study proposes a unified statistical framework using flexible parametric models to simultaneously assess correlate of protection and sieve effects in vaccine efficacy trials.
Enables integrated vaccine trial analyses; extends competing-risks methods for future correlate and sieve evaluations.
Many infectious diseases are well prevented by proper vaccination. However, when a vaccine is not completely efficacious, there is great interest in determining how the vaccine effect differs in subgroups conditional on measured immune responses postvaccination and also according to the type of infecting agent (eg, strain of a virus). The former is often called correlate of protection (CoP) analysis, while the latter has been called sieve analysis. We propose a unified framework for simultaneously assessing CoP and sieve effects of a vaccine in a large Phase III randomized trial. We use flexible parametric models treating times to infection from different agents as competing risks and estimated maximum likelihood to fit the models. The parametric models under competing risks allow for estimation of both cumulative incidence-based contrasts and instantaneous rates. We outline the assumptions with which we can link the observable data to the causal contrasts of interest, propose hypothesis testing procedures, and evaluate our proposed methods in an extensive simulation study.
No takes yet. Share an insight, caveat, or question.
Gabriel et al. (2019) studied Infectious diseases. Unified statistical framework for differential vaccine efficacy was evaluated. A proposed unified statistical framework using flexible parametric models under competing risks allows for simultaneous assessment of correlate of protection and sieve effects in vaccine trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: